NDC 0032-3016 – Creon

Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase 180000 [USP'U]/1; Pancrelipase Protease 114000 [USP'U]/1 · Capsule, Delayed Release Pellets · Oral

Human Prescription Drug 2 recalls

Product NDC0032-3016

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release Pellets
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
March 14, 2013
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (3)

Package NDCDescriptionSince
0032-3016-12 sample1 BOTTLE in 1 CARTON (0032-3016-12) / 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLEMar 14, 2013
0032-3016-13100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-13)Mar 14, 2013
0032-3016-28250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-28)Mar 14, 2013

Recalls mentioning this NDC

Other Creon products